World of vaccines is a ‘fiendishly’ complex one


In response to Will Africa’s best shot at at Covid-19 vaccine be enough?, Mail & Guardian (12 October)

Laura López González doubts that the only truly global vaccine-based solution to Covid-19, the Covax partnership, will reach those most in need because any intellectual property (IP) relating to eventual vaccines will remain with the organisations that developed them.

It is important that Africa, along with other regions of the Global South, builds its own vaccine-manufacturing capacity and it is important that leaders from the public and private sector do everything they can to drive forward this goal. Sadly, however, it is just not realistic to believe that the provision of technological know-how to every country in the world will enable us to produce the number of doses we need, in the time we need them, to defeat the pandemic.

The world of vaccines, like many other worlds, does not work like that. For one thing, it would be impossible for any organisation to develop vaccines were there not an economic incentive in the first place. More significantly, manufacturing of vaccines is fiendishly complex, and often requires thousands of individual steps: to put one foot wrong would put lives at risk.

In acknowledgement of the fact that supply constraints, not IP issues, will be the biggest barrier to achieving global coverage of Covid-19 vaccines, Covax is instead focusing on raising enough cash to incentivise manufacturers to make enough doses to satisfy global demand. As well as making sure countries get enough life-saving, cold-chain infrastructure to eventually deliver them.

This may come at a cost, but it leaves behind a legacy of sustainable economic development. Already, Covax has inked contracts for hundreds of millions of doses of Covid-19 vaccines from manufacturers in the Global South and the upshot of this is a more diverse, more competitive market for vaccines that has been proven to bring down costs dramatically in the long run.

Delivering Covid-19 vaccines to the world could possibly be the largest global health deployment in history. It is literally all hands on deck, and we will only succeed if we work together to make it happen.

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Thabani Maphosa
Thabani Maphosa is managing director of Gavi, the vaccine alliance

Related stories


Subscribers only

Vodacom swindled out of more than R24m worth of iPhones

A former employee allegedly ran an intricate scam to steal 8700 phones from the cellular giant

Come what may, the UIF will pay

The fund – the main safety net for unemployed workers – will run at an almost R20-billion deficit

More top stories

We will find resources to ensure the Zondo commission completes...

Justice Minister Ronald Lamola says his department will ensure the state capture commission is afforded the financial resources to complete its work, despite the treasury’s uncertainty

Covid-19 variant may protect people against reinfection and other variants,...

The 501Y.V2 strain produces strong antibodies, but it’s not known how long immunity lasts, so being vaccinated remains essential

Tobacco industry calls Dlamini-Zuma’s bid to appeal ban a...

The minister could spend the state’s money on fighting Covid-19 and cigarette cartels, tobacco manufacturers argue

Zondo commission: Glencore sold Optimum to portray me as a...

Former Eskom chief executive paints himself as the victim of a plot at the hands of President Cyril Ramaphosa’s former business associates

press releases

Loading latest Press Releases…